- ICH GCP
- Yhdysvaltain kliinisten tutkimusten rekisteri
- Kliininen tutkimus NCT07506980
Hoitajajohtoinen intervention itsehoidon noudattamiseen ja elämänlaatuun (Selfcare)
Hoitajajohtoisen interventioiden vaikutus hemodialyysipotilaiden itsehoidon noudattamiseen ja elämänlaatuun.
Tausta: Hemodialyysi on yleisin hoitomuoto kroonista munuaissairautta sairastavilla potilailla. Suurin osa dialyysiä saavista ihmisistä elää keskimääräistä heikompaa elämänlaatua. Ruoan ja nesteiden noudattaminen, fyysisen aktiivisuuden harjoittaminen sekä masentuneisuuden ja ahdistuksen tunteet vaikuttavat kaikki elämänlaatuun. Sairaanhoitajilla on keskeinen rooli potilaskoulutuksessa ja käyttäytymisen tukemisessa. Sairaanhoitajajohtoiset interventiot, erityisesti koulutusohjelmat (kannettavaan tietokoneeseen perustuvat), yhdistettynä muistutuksiin ja opetusmateriaaleihin, voivat parantaa potilaiden tietämystä, hoidon noudattamista ja elämänlaadun parantumista.
Metodologia Tutkimus hyödyntää kvantitatiivista tutkimussuunnittelua. Tutkimus toteutetaan yhdessä yksityisessä kolmannen tason hoitolaitoksessa. Ensin päivä ja vuoro arvottiin satunnaisesti, ja kyseisenä päivänä ja vuorossa olevat osallistujat luokitellaan ryhmään A ja ryhmään B. Tämän jälkeen kelpoisuuskriteerit arvioidaan ja perustason arviointi suoritetaan. Mukavan otannan tekniikkaa käytetään tutkimusotoksen valintaan. Kummassakin ryhmässä on vähintään 56 osallistujaa. Siksi yhteensä on vähintään 112 osallistujaa. Toinen ryhmä saa sairaanhoitajajohtoisia interventioita (ryhmä A), ja kontrolliryhmä (ryhmä B) saa tavanomaista rutiinihoidon.
Sairaanhoitajajohtoinen interventio koostuu 4 kannettavaan tietokoneeseen perustuvasta koulutus- ja neuvontasessiosta, 4–6 puhelinmuistutuksesta sekä itsehoidosta kertovan esitteen jakamisesta. Kaikki neljä sessiota toteuttaa erikoissairaanhoitaja tai sairaanhoitaja, jolla on vähintään vuoden työkokemus dialyysiyksikössä. Jokainen sessio toteutetaan kerran yhdestä kahteen viikkoon. Ensisijainen tuloksen mittari on itsehoidon noudattaminen. Itsehoidon noudattamista mitataan suoraan kliinisten parametrien (interdialyyttinen painonnousu) avulla sekä subjektiivisesti kasvokkain tapahtuvien haastattelujen kautta. Potilaiden sairauskertomuksia tarkastellaan. Toissijainen tuloksen mittari on elämänlaadun pistemäärä. Riippumaton arvioija (laskija) mittaa tuloksen ajanhetkillä T1 ja T2, jotka suoritetaan 2 kuukauden (T1) ja 6 kuukauden (T2) kuluttua perustasosta.
Analyysi suoritetaan Stata-ohjelmistolla versio 14. Kuvailu tilastot, kuten frekvenssi, prosenttiosuus, keskiarvo±keskihajonta, mediaani ja kvartiiliväli, perustuvat datan luonteeseen. Samoin päätelmällisiä tilastoja, kuten t-testiä ja lineaarista regressioanalyysiä, käytetään kahden ryhmän keskiarvojen eron selvittämiseen. Tuloksia pidetään tilastollisesti merkitsevinä tasolla p<0,05 95 % luottamusvälillä.
Tämän tutkimuksen vahvuus on se, että siihen sisällytetään sekä kliiniset että subjektiiviset noudattamisen parametrit sekä elämänlaadun arviointi. Kvalitatiivisen lähestymistavan käyttö tekijöiden, kuten koulutus- ja neuvontasessioiden sopivuuden, sekä noudattamisen edistäjien ja esteiden selittämisessä auttaa edelleen interventioiden muokkaamisessa. Jos menetelmä osoittautuu tehokkaaksi, tämä on kustannustehokas keino parantaa elämänlaatua. Tätä voidaan jatkaa säännöllisesti samassa keskuksessa, ja sitä voidaan hyödyntää myös muissa.
Tutkimuksen yleiskatsaus
Tila
Ehdot
Yksityiskohtainen kuvaus
Introduction
Chronic kidney disease (CKD) is an abnormality in the structure and function of the kidney that has been present for at least three months and has health implications. It is classified based on the cause, glomerular filtration rate, and albuminuria rate.1 The worldwide prevalence of CKD is 10%, with more than 800 million people affected by it.2 The nationwide population-based survey of Nepal showed that the overall prevalence of CKD is 6.6%, with approximately 1,895,080 people affected by it.3
People with CKD cannot filter out urine; as a result, the patient has retention of metabolic wastes and increased metabolic acidosis. People with CKD develop signs and symptoms of uremia, like shortness of breath, leg swelling, muscle cramps, heartburn, itching, sexual dysfunction, poor sleep, pain, drowsiness, joint pain, reduced mobility, and fatigue. These changes in the body result in peripheral edema, hypertension, reduced exercise capacity, and the development of cardiovascular disease. 1, 4
The treatment options available for kidney disease are lifestyle changes, medicines, dialysis, and kidney transplantation. In dialysis, there are peritoneal dialysis and hemodialysis.1, 4 Worldwide, an estimated 4.9 million people are receiving hemodialysis treatment.5 In America, out of 808,000 patients with kidney failures, about 556,000 people are undergoing hemodialysis treatment.6 In Nepal, approximately 3,775 people receive hemodialysis treatment from 60 centers.7
Hemodialysis, which uses an artificial kidney, removes extra fluids, toxins, and solutes.8 Kidney Disease Outcome Quality Initiatives (K/DOQI) recommends thrice-weekly maintenance hemodialysis with a minimum of three hours per session.9 Most of the patients in Nepal undergo twice-weekly in-center hemodialysis sessions. 7, 10 People undergoing hemodialysis have multiple problems like fluid and electrolyte imbalance, volume overload, swollen ankles, shortness of breath, tiredness, and difficulty sleeping.11
Hemodialysis patients must follow their dialysis schedule and comply with dietary recommendations and fluid and salt restrictions. Besides this, there is a fear of morbidity and mortality in these groups of patients. 12 Mental health issues like anxiety and depression are highly prevalent in people with hemodialysis, at 49.6% and 55%, respectively.13 The prevalence of anxiety ranges from 27-69 % and depression from 11% -78% in the context of Nepal.14-19 The Presence of these issues affects various aspects of physical, mental, emotional, social, and family domains of quality of life and vice versa. 13 The dialysis and the presence of multiple symptoms reduce the person's ability to work, and these patients need to adhere to treatment.20
Self-care adherence is the specific recommended behaviors a person initiates and maintains to improve and sustain their health. These are the combination of activities that include controlling weight, adherence to prescribed medications, eating a healthy diet, altering fluid and salt intake, engaging in adequate physical activity, participating in exercise, ventilating feelings, and alcohol and smoking cessation.21,22 In dialysis patients, objective measures of self-care adherence can be assessed by evaluating interdialytic weight changes, blood pressure, serum phosphate and sodium levels, and functional independence.23 The improvement in self-care adherence score correlated with the improvement in quality of life score. 24
Research suggests that the pooled prevalence of worldwide dietary non-adherence ranges from 47% to 73%, and fluid non-adherence ranges from 50% to 71%.25 In Nepal, adherence to fluid and diet was 49% and 43%, respectively.26 The patient on dialysis has to restrict their salt intake to less than 2 gm /day and fluid intake to less than 500 ml plus previous output to maintain their inter-dialytic weight gain.4 Inter-dialytic weight gain is an important assessment tool for salt and fluid intake and an essential parameter of salt and fluid adherence. The weight should be less than 1.5 kg between two hemodialysis sessions, and there should be no more than a 1 kg weight gain per day between sessions.27 The inter-dialytic weight gain percentage should be lower than 4 to 4.5 % of dry weight. Inter-dialytic weight gain in kilograms is the difference between pre-dialysis and post-dialysis weights. The inter-dialytic weight gain in percentage is the difference between pre- and post-dialysis weights divided by the dry weight in kg, multiplied by 100.28
Physical activity is another essential part of self-care adherence.23 A large survey across 12 countries found that 44% had never been involved in any exercise.29 A study from Nepal showed that only 42.5% were involved in some physical activity, whereas 57.5% were not involved in any kind of physical activity.30 The participants in another study on knowledge of self-care management scored the lowest on the knowledge level of exercise (47.27±20.59 out of 100).31 Exercise not only prevents complications but also contributes to better health. It is the leading factor in improving the performance status and quality of life of people undergoing hemodialysis. 32, 33 Established guidelines recommend that hemodialysis patients perform 150 minutes of moderate-intensity activity or 75 minutes of vigorous activity per week. These can be done during or outside dialysis.34, 35
According to the Centers for Disease Control and Prevention, health-related quality of life is "an individual's or group's self-perception of their physical and mental health over time." It is a measure of a person's being.36 Patients undergoing hemodialysis experience multiple symptoms and lifestyle changes, and because of this, their everyday health-related quality of life (HRQOL) is affected. HRQOL is a key outcome, serving as an indicator of the impact of health status on quality of life and as a powerful predictor of the relative risk of death and hospitalization. 37 Several studies have shown that hemodialysis patients experience a decreased quality of life. 38-42
Nursing-led interventions are a care delivery model in which a nurse initially assesses, evaluates, and, based on these findings, plans her intervention or seeks a multidisciplinary/interdisciplinary effort to address the patient's problems.43
The KDIGO guideline 2024 recommends that people with chronic kidney disease receive care from a multidisciplinary care team. This care should include individualized education and counselling on lifestyle modification, including diet, exercise, smoking cessation, medication, and psychological support.1 A systematic review and meta-analysis on the role of educational/cognitive, counseling/behavioral interventions led to a significant reduction in interdialytic weight gain (mean difference in weight- 0.15 kg) in the intervention group compared to no intervention. Psychological interventions were associated with a reduction in interdialytic weight gain of 0.26 kg compared with the intervention group.44 Other studies have failed to demonstrate significant differences in objective self-care adherence parameters between groups.45, 46
The study conducted in Iran showed that the nurse-led education program, together with nurse-led telephone follow-up and a distribution of patient education booklets,t showed significant improvement in adherence score compared to control groups.47 Another study conducted in Turkey, where nurse-led telephone-based education and counselling resulted in significant improvements in self-care skills and quality of life.48
General Objective: To evaluate the effect of nurse-led interventions on self-care adherence and quality of life among patients undergoing hemodialysis
Specific Objectives:
- To compare the average values of self-care adherence score (adherence to diet and fluid, exercise, and clinical parameters) between the nurse-led intervention group and the usual care group at 4 months and at 6 months.
- To compare the quality of life (QOL) scores between the intervention and usual care groups at 6 months baseline.
Research Hypothesis
- There is no significant difference in the mean values of self-care adherence among patients undergoing hemodialysis who receive a nurse-led intervention compared to those who receive usual care at 4 and 6 months.
- There is no significant difference in the average Kidney Disease Quality of Life (KDQOL) score between patients undergoing hemodialysis who receive a nurse-led intervention and those who receive usual care over 6 months.
Study Variables Independent variables: Nurse-led intervention Nurse-led intervention: Comprises an education and counselling session, a reminder call, and distribution of "Self-care booklet for hemodialysis patients."
Education and counselling session by nurses (laptop-based):
- 1st session (1 to 2 weeks of about 20 minutes): By this session, the nurse makes patients aware of existing interdialytic weight gain status, blood pressures, body mass index, and physical activity. Covers a brief introduction to kidney functions, chronic kidney disease, risk factors, treatment options, dry weight, its importance, and motivational examples. The participants were counselled on the need for behavior change, and assessed whether their behavior is problematic.
- 2nd Second session (3 to 4th weeks, about 30 minutes): Increase awareness about healthy behavior, introduction to diet, salt, and fluid, and dietary recommendation session for electrolytes like sodium, sources of potassium and phosphorus, and protein-rich foods, monitoring these parameters in blood, strategies to reduce salt and fluid intake
- 3rd Session (5th to 6th weeks, duration 25 min): 3rd session, increase awareness and importance of physical exercise with focus on aerobic, stretching exercises, and deep breathing exercises
- 4th session (7 to 8 weeks, duration 25 to 30 min): Introduction to mental health, importance of mental health, common mental health problems in hemodialysis patients, strategies to improve mental health ( ventilation of feelings, quit smoking),
- Reminder call: Patients will be called once a week on a non-dialysis day. Patient will receive six calls altogether after the third session, once a week on a non-dialysis day. The call will last 3-5 minutes over 6 weeks. The main focus will be on the targeted interdialytic weight control (<1.5kg) relating to patients' baseline values and between values. Furthermore, patients are encouraged to limit intake of foods rich in sodium, potassium, and phosphorus. Patients are encouraged to engage in physical activity (exercise) and to vent their feelings to a close person.
- Self-care booklet for hemodialysis patients: Patient will be provided with the small booklet at the end of the last educational session. This booklet has been constructed and reviewed by two nephrologists, two nurse specialists, a physiotherapist, a psychologist, and a nutritionist.
Primary variables: Self-care adherence Clinical parameters: interdialytic weight gain Subjective adherence score: Will be assessed by the self-constructed tool on diet, fluid, and salt restriction, as well as monitoring of weight and blood pressure. Physical activity score using the International Physical Activity Questionnaire.
Secondary variables: Quality of life, Blood pressure, and Body mass index. Quality of life will be subjectively assessed by the Kidney Disease Quality of Life score (KDQOL-SF 36)
Site and its Justification: This study will be conducted at Nepal Medical College and Teaching Hospital. This center is a tertiary care center with around 450 beds. The center has started hemodialysis services around two decades ago (2005, Feb 16). It is the renowned center for hemodialysis services, with approximately 29-31 patients undergoing hemodialysis per shift, and about 213 patients currently receiving this service.
Research Design: Quantitative design. This study will be conducted to assess the effects of nurse-led intervention on self-care adherence and quality of life among patients undergoing hemodialysis.
Study design: Quasi-experimental design.n Study site: Nepal Medical College Teaching Hospital.Study population: Patients presenting to the dialysis unit at NMCTH will be included.
Inclusion criteria: 1) All the patients undergoing hemodialysis who have interdialytic weight gain ≥1.5kg will be approached.d 2) Willing to participate in the study.y 3) Undergoing dialysis at least 2 times a week
Sample size Sample size is calculated using Stata software, assuming 5% alpha (a), 80% power (b), a 1:1 allocation ratio for the control and experimental groups, and an effect size of 1.1 for interdialytic weight, with standard deviations of 1.75 for the control group and 1.98 for the experimental group. Mean interdialytic weight of 2.31kg for the control group and 1.21 (I ), study conducted by Pradhan et al in India.47 The sample size calculation is done through the software clincalc .5150 Sample size calculation: n = sample size required in each group µ1=mean change in IDWG from baseline to week 6 in usual care group (2.31kg) µ2=mean change in IDWG from baseline to week 6 in intervention group (1.21 kg) µ1 -µ2= effect size or clinically significant difference =1.1kg σ = standard deviation of experimental group Zα/2: This depends on the level of significanc;, for 5,% this is 1.96 Zβ: This depends on power; for 80%, this is 0.84 Total (n) = 51 hemodialysis patients in each group Calculation of dropout of 10%= 5 patients in each group In total,l 112 patients undergoing hemodialysis will be the final sample size,e and this is the minimum sample size required for the study.
Total patients undergoing hemodialysis = 213 Dialysis 2 times a week =213-44 (3 times in a week) =169 IDWG <1.5 kg (14%) 24 = Meeting eligiblity criteria=169-24=145
Sampling technique: Convenience sampling will be used to select participants for the intervention. Each week, the dialysis patient will be repeated (Sunday/Wednesday, Monday/ Thursday, Tuesday/ Friday). So, each week and day, almost the same patients will be repeated. Patients are grouped by the day they come in due to ethical and moral considerations. Giving more focused care to one patient and giving usual care to others does not look practical. So, selection is done based on the day. (Sunday: Intervention/control), Monday (Intervention/control) Shift-wise for Tuesday shift (Tuesday morning: Intervention/control), Tuesday afternoon (Intervention/control).
Number of participants and Justification:
The hemodialysis unit of Nepal Medical College serves about 213 patients. This includes patients undergoing dialysis 2 and three times a week. The total number of patients undergoing dialysis twice a week is 169. Considering patients with interdialytic weight gain of at least 1.5 kg, the minimum sample size is 112.
Sampling Technique A convenient sampling technique will be used for the quantitative study. Criteria for sample selection Inclusion criteria: 1) All patients undergoing hemodialysis who have interdialytic weight gain ≥1.5kg will be approached. 2) Willing to participate in the study. 3) Undergoing dialysis at least 2 times a week 4) On hemodialysis for at least 3 months 5) Age 18- 69 years Exclusion Criteria: Difficulty in seeing and or hearing problems, Cognitive problems
Data Collection Technique Quantitative study: Clinical parameters such as interdialytic weight gain, blood pressure, and height and weight for the calculation of Body mass index will be collected from hospital records.
Other outcome measures, like self-care adherence( diet and fluid - self-constructed an international physical activity questionnaire) and quality of life, will be assessed through direct face-to-face interviews. :
Data collection tools Tools of data collection: Clinical parameters from patients' charts, like lab values, serum potassium, serum phosphorus, dry weight from patient charts, lab reports, whereas height, weight, and BP were recorded from the patients' medical records.
Tools of data collection: Clinical parameters from patients' chart, like lab values, serum potassium, serum phosphorus, dry weight from patient charts, lab reports whereas height, weight, and BP from the patient chart.
Interdialytic weight gain (kg): In this study, interdialytic weight gain is defined as the difference between the post-dialysis weight of the prior session and the pre-dialysis weight of the current session. The average weight over the last 2 weeks (4 readings) will be considered the interdialytic weight. Interdialytic weight gain >1.5 kg is considered nonadherence.
Weight: Weight will be measured by the flat hospital digital weighing scale, which has been regularly used in the respective hospital, and is measured in kilograms.
Blood Pressure: It will be recorded from patients' medical records, measured using an aneroid blood pressure monitoring device. The average blood pressure over the last four weeks before hemodialysis will be used. Blood pressure will be measured after sitting for at least 5 minutes
. Both systolic and diastolic blood pressure will be considered. Body Mass Index (BMI): Body mass index will be measured by the formula weight in kg divided by height in m2 (weight in kg/height in m2). The weight is considered the average of the previous four post-dialytic weights from the baseline. A BMI of 18.5 to 24.9 is considered normal.
Self-care adherence: This will be measured subjectively by two separate tools. Adherence to diet and fluid intake will be measured using a self-constructed tool developed by the researcher. Engagement in physical activity will be measured by the standard tool. The participants will be asked, via interview, how frequently they followed dietary and fluid recommendations in the past 2 weeks using a rating scale. There are altogether 26 questions, among which 21 are positive responses with always =5, often = 4, sometimes = 3, rarely=2, and never=1, whereas items (2, 4, 6, 10, 12, 19) are negative scoring items. A higher score indicates higher adherence. The highest possible score is 130, and the lowest possible score is 26. The instrument can be used by taking the mean or median of the obtained score as the cut-off for adherence or non-adherence. The questionnaire has been constructed by reviewing various guidelines and studies (1, 9, 52-53 Among 26 questions, 8 are related to salt, 9 to diet, 5 to fluids, and 4 to monitoring as per advice. The validity of the tool was maintained with a CVI score of 1, and the Cronbach's alpha after pretesting, involving 30 participants at Dhulikhel Hospital, was 0.70.
International Physical Activity Questionnaire (IPAQ): The short form comprises 7 questions across 4 activity domains (vigorous, moderate, walking, and sitting). This tool has been modified; instead of the original tool's continuous 10-minute activity, the cumulative activity in minutes over a day is considered. Each activity domain includes: Frequency (days/week) and Duration (minutes/day) of certain activities. Physical activity is scored in MET minutes/week (MET = Metabolic Equivalent of Task). The total Physical Activity Score = sum of MET min/week from all activities. E.g.. MET minutes for moderate activity are 4.4. Suppose someone spends 3 days, averaging 30 min of bicycling or carrying light loads. Then it should be 4 X 3 X 30= 360 MET min/week. Similarly, METS for vigorous activity is 8, moderate intensity 4, and walking 3.3. The tool can be used in numerical or categorical scales. A higher score means a high activity level. A score <600 MET min/week is considered a low activity level; 600-2999 is moderate;>3000 is high. The test-retest reliability of IPAQ is 0.74, based on data from 12 countries (51, 54 The participants will be asked how much time they spent in a particular domain within the last seven days. The content validity index obtained after validating with five experts was 1, and the test-retest reliability obtained after pretesting it on 30 patients undergoing hemodialysis at Dhulikhel Hospital was .89.
Quality of life:
Quality of life in this study refers to individuals' perceived functioning in physical and mental domains resulting from chronic disease. In this study, it will be measured by the Kidney Disease Quality of Life Questionnaire (KDQOL). This question is a Likert-type scale with 36 items, ranging from 2- to 6-point. It has four domains: the SF-12 physical component and mental component summary scales on general health, burden and kidney disease, symptoms and problems, and the effect of kidney disease on daily life. A higher score indicates a better quality of life. This tool is highly reliable, with a Cronbach's alpha of 0.7. 25
Plan for data management and analysis Data Analysis: Will be done using Stata version 14. Collected data will be checked upon completion of the study and entered into an Excel 2010 sheet. Then this will be extracted in Stat 14 software.
Descriptive statistics such as frequency, percentage, and mean/median, as well as standard deviation/interquartile range, will be used based on the nature of the data.
Similarly, inferential statistics such as t-tests and linear regression analysis will be used to determine the difference in mean scores between two groups. The type of statistical analysis may change depending on the nature of the data.
Expected outcome of the research results Improvement in the subjective adherence score and objective parameters (decrease in interdialytic weight gain and blood pressure), and improvement in the quality of life score.
Opintotyyppi
Ilmoittautuminen (Arvioitu)
Vaihe
- Ei sovellettavissa
Yhteystiedot ja paikat
Opiskeluyhteys
- Nimi: Abja Sapkota, Masters in Nursing
- Puhelinnumero: (+977)9841370401
- Sähköposti: abjasapkota@nmcth.edu
Opiskelupaikat
-
-
Bagmati
-
Gokarna, Bagmati, Nepal, 44600
- Rekrytointi
- Nepal Medical College Teaching Hospital
-
Ottaa yhteyttä:
- Abja sapkota, Masters in Nursing
- Puhelinnumero: 977-01-99841370401
- Sähköposti: abjasapkota@nmcth.edu
-
Kathmandu, Bagmati, Nepal, 4660
- Rekrytointi
- Nepal Medical College and Teaching Hospital
-
Ottaa yhteyttä:
- Abja Sapkota, Masters in Nursing
- Puhelinnumero: 977-9841370401
- Sähköposti: abjasapkota@nmcth.edu
-
Päätutkija:
- Abja Sapkota, Masters in Nursing
-
-
Osallistumiskriteerit
Kelpoisuusvaatimukset
Opintokelpoiset iät
- Aikuinen
- Vanhempi Aikuinen
Hyväksyy terveitä vapaaehtoisia
Kuvaus
Sisällytyskriteerit:
Ikä 18–69 vuotta. Interdialyysipainonnousu yli tai yhtä suuri kuin 1,5 kg. Dialyysihoidossa kahdesti viikossa viimeisen 3 kuukauden ajan. Suostumus annetaan suullisesti ja kirjallisesti. Käytössä on matkapuhelin, jota voi käyttää itse tai perheenjäsenten kanssa.
Poissulkemiskriteerit: Itse raportoitu kuulovaikeus ja näkövaikeus. Kognitiiviset ongelmat kuten muistinmenetys, kielelliset vaikeudet ja unohtelu. Sydänongelmat, kuten dysrytmia, kammiosairaus tai alentunut ejektiofraktio, vaativat happea dialyysin aikana.
Opintosuunnitelma
Miten tutkimus on suunniteltu?
Suunnittelun yksityiskohdat
- Ensisijainen käyttötarkoitus: Tukevaa hoitoa
- Jako: Ei satunnaistettu
- Inventiomalli: Rinnakkaistehtävä
- Naamiointi: Ei mitään (avoin tarra)
Aseet ja interventiot
Osallistujaryhmä / Arm |
Interventio / Hoito |
|---|---|
|
Ei väliintuloa: Ryhmä B, Tavallinen ryhmä, kontrolliryhmä
Kontrolliryhmä saa tavanomaisen hoidon, säännöllisen lääkärinkierron, neuvot nesteiden hallinnasta, jos dialyysivälisen painonnousun ylittää 3-4 kg, ja laboratorioraporttien tarkistuksen
|
|
|
Kokeellinen: Group A, Nurse led intervention ( educational session, telephone reminder, distribution of booklet
This group will receive 4 educational and counsellings sessions, for one month for hemodialysis patients.
Similarly, reminder calls will be sent (4-6 in number) and small booklet on self care will be distributed to group A. This group will be assessed at baseline and at 4 months(T1) and 6 months (T2) from baseline assessment (T0)
|
1. Hoitajien koulutus- ja neuvontasessio (kannettavaan tietokoneeseen perustuva): 4 sessiota, jokainen 20–30 minuuttia
Muut nimet:
Itsetekemisen kirjanen hemodialyysipotilaille.
Kirjassa on johdatus munuaisiin, krooniseen munuaissairauteen ja niiden toimintaan.
Tämä kirja kattaa lähes kaiken sisällön, jota käsitellään keskustelutilaisuuksissa.
Se sisältää kuvan paikallisesti saatavasta lusikasta, jossa on 5 grammaa suolaa, paikallisesti saatavasta lasista, jossa on 100 ml:n viiva, sekä luettelon kasviksista ja hedelmistä niiden kalium- ja fosforipitoisuuksien milligrammoina.
Participants will be called 4-6 times , once a week on non dialysis day for 3-5 minutes after 2nd session up to 4 months from baseline .
|
Mitä tutkimuksessa mitataan?
Ensisijaiset tulostoimenpiteet
Tulosmittaus |
Toimenpiteen kuvaus |
Aikaikkuna |
|---|---|---|
|
Change in Interdialytic weight gain in kilograms
Aikaikkuna: The time frame for the assessment of the primary outcome measure is at 4 months and 6 months from the baseline.
|
Interdialytic weight gain (IDWG): The IDWG is the difference between the pre-dialysis weight and the post-dialysis weight of the last session. The weight will be taken from the patient's charts, which were recorded in kilograms. In this study, IDWG will be the average of the weights taken in the last two weeks. Altogether, there were four predialysis weights and four post dialysis weight. The average of the four interdialytic weights will be considered. The usual practice for the measurement of the weight is by the use of the dialysis weighing scale that has been in use regularly for dialysis patient. The difference in the interdialytic weight at baseline and at 4 months and 6 months from baseline between the usual care and intervention groups |
The time frame for the assessment of the primary outcome measure is at 4 months and 6 months from the baseline.
|
|
Self care adherence : The self care adherence will be measured by two instruments through interview methods. For diet and fluid self constructed tools will be used and for physical activity international physical activity questions will be adopted.
Aikaikkuna: This outcome will be measured at 4 months and at 6 months from the baseline . The outcome will be assessed by the researcher along with trained eneumerator having bachelor degree in nursing .
|
Measured subjectively by two separate tools. Adherence to diet and fluid: Measure by the self-constructed tool developed by the researcher.The tool contains 26 items related to salt, fluid, diet, and regular monitoring of weight and blood pressure. Participants will be asked how frequently they followed the diet and fluid recommendations provided by the health care providers. A higher score indicates higher adherence. The difference between the score at baseline and at 4 months and 6 months will be assessed. Adherence to physical activity : The Engagement in physical activity will be measured by the standard tool international physical activity questionnaire. Here also highest score indicates higher adherence and lower score indicates lower adherence. The difference between the activity score at baseline and at 4 and 6mths will be assessed. |
This outcome will be measured at 4 months and at 6 months from the baseline . The outcome will be assessed by the researcher along with trained eneumerator having bachelor degree in nursing .
|
Toissijaiset tulostoimenpiteet
Tulosmittaus |
Toimenpiteen kuvaus |
Aikaikkuna |
|---|---|---|
|
Elämänlaatupisteet
Aikaikkuna: Pistemuutosta verrataan lähtötilanteessa ja 6 kuukauden kohdalla.
|
Elämänlaatua arvioidaan käänettyä nepalinkielistä munuaistautien elämänlaatukyselyä käyttäen.
Korkeampi pistemäärä osoittaa parempaa elämänlaatua. Pistemäärän muutosta arvioidaan 6 kuukauden kuluttua ja vertailukohtana käytetään alkuperäistä pistemäärää. |
Pistemuutosta verrataan lähtötilanteessa ja 6 kuukauden kohdalla.
|
|
Body mass index
Aikaikkuna: baseline and at 4 and 6 months
|
Body mass index will be measured by the weight in kg divided by height in m2 (kg/m2).
The weight will be measured by the average of the four post dialysis weight.
It is the difference in BMI at the baseline and 6 months
|
baseline and at 4 and 6 months
|
|
pre dialysis systolic blood pressure
Aikaikkuna: 4 months and 6 months baseline . The difference in pre hemodialysis systolic blood pressure at baseline and at 4 and 6 months will be used .
|
The pre hemodialysis blood pressure will be recorded from the patients chart.
The average of the four pre hemodialysis systolic blood pressure will be considered as the systolic blood pressure .The usual practice of the blood pressure measurement is by the aneroid blood pressure measurement.
This will be done by the registered nurse with the patient sitting on a chair, with the feet touching the floor.
The patient will be sitted on a chair for at least five minutes before taking the blood pressure.
This is measured in mm of Hg .
|
4 months and 6 months baseline . The difference in pre hemodialysis systolic blood pressure at baseline and at 4 and 6 months will be used .
|
|
pre hemodialysis diastolic blood pressure
Aikaikkuna: at 4 months and 6 months from baseline. The difference in diastolic blood pressure at baseline and at 4 months and 6months will be measured.
|
Description: The pre hemodialysis blood pressure will be recorded from the patients chart.
The average of the four pre hemodialysis diastolic blood pressure will be considered as the diastolic blood pressure .The usual practice of the blood pressure measurement is by the aneroid blood pressure measurement.
This will be done by the registered nurse with the patient sitting on a chair, with the feet touching the floor.
The patient will be sitted on a chair for at least five minutes before taking the blood pressure.
This is measured in mm of Hg.
|
at 4 months and 6 months from baseline. The difference in diastolic blood pressure at baseline and at 4 months and 6months will be measured.
|
Yhteistyökumppanit ja tutkijat
Julkaisuja ja hyödyllisiä linkkejä
Yleiset julkaisut
- Tentori F, Elder SJ, Thumma J, Pisoni RL, Bommer J, Fissell RB, Fukuhara S, Jadoul M, Keen ML, Saran R, Ramirez SP, Robinson BM. Physical exercise among participants in the Dialysis Outcomes and Practice Patterns Study (DOPPS): correlates and associated outcomes. Nephrol Dial Transplant. 2010 Sep;25(9):3050-62. doi: 10.1093/ndt/gfq138. Epub 2010 Apr 13.
- Kidney Disease: Improving Global Outcomes (KDIGO) CKD Work Group. KDIGO 2024 Clinical Practice Guideline for the Evaluation and Management of Chronic Kidney Disease. Kidney Int. 2024 Apr;105(4S):S117-S314. doi: 10.1016/j.kint.2023.10.018. No abstract available.
- Baker LA, March DS, Wilkinson TJ, Billany RE, Bishop NC, Castle EM, Chilcot J, Davies MD, Graham-Brown MPM, Greenwood SA, Junglee NA, Kanavaki AM, Lightfoot CJ, Macdonald JH, Rossetti GMK, Smith AC, Burton JO. Clinical practice guideline exercise and lifestyle in chronic kidney disease. BMC Nephrol. 2022 Feb 22;23(1):75. doi: 10.1186/s12882-021-02618-1. No abstract available.
- Kovesdy CP. Epidemiology of chronic kidney disease: an update 2022. Kidney Int Suppl (2011). 2022 Apr;12(1):7-11. doi: 10.1016/j.kisu.2021.11.003. Epub 2022 Mar 18.
- Arad M, Goli R, Parizad N, Vahabzadeh D, Baghaei R. Do the patient education program and nurse-led telephone follow-up improve treatment adherence in hemodialysis patients? A randomized controlled trial. BMC Nephrol. 2021 Apr 7;22(1):119. doi: 10.1186/s12882-021-02319-9.
- Howren MB, Kellerman QD, Hillis SL, Cvengros J, Lawton W, Christensen AJ. Effect of a Behavioral Self-Regulation Intervention on Patient Adherence to Fluid-Intake Restrictions in Hemodialysis: a Randomized Controlled Trial. Ann Behav Med. 2016 Apr;50(2):167-76. doi: 10.1007/s12160-015-9741-0.
- Bossola M, Pepe G, Antocicco M, Severino A, Di Stasio E. Interdialytic weight gain and educational/cognitive, counseling/behavioral and psychological/affective interventions in patients on chronic hemodialysis: a systematic review and meta-analysis. J Nephrol. 2022 Nov;35(8):1973-1983. doi: 10.1007/s40620-022-01450-6. Epub 2022 Sep 16.
- VR V, Kang HK. The effect of nurse-led interventions on non-adherence to dietary and fluid restrictions among adults receiving haemodialysis: a randomised controlled trial. Journal of Kidney Care 2023 ; 8(1):12-25
- Tutur I, Bicer EK. The Effect of Nurse-Led Telephone Patient Education and Counseling on Disease Management, Quality of Life, and Self-Care Behaviors in Hemodialysis Patients. Worldviews Evid Based Nurs. 2025 Dec;22(6):e70074. doi: 10.1111/wvn.70074.
- Sapkota A, Sedhain A, Kc T, Sigdel S, Subedi S. Adherence to Treatment among Patients With End-Stage Renal Disease Undergoing Hemodialysis In Selected Centers In Nepal. J Nepal Health Res Counc. 2022 Jun 2;20(1):72-78. doi: 10.33314/jnhrc.v20i01.3828.
- KDOQI-Clinical-Practice-Guideline-Hemodialysis-Update_Public-Review-Draft-FINAL_20150204.
- Sharma I, Bhattarai M, Sigdel MR. Global Dialysis Perspective: Nepal. Kidney360. 2022 Apr 27;3(7):1269-1274. doi: 10.34067/KID.0001672022. eCollection 2022 Jul 28. No abstract available.
- Bing ZJ, Yap SC, Yie LW. Development of Dialysis and Leakage Detection on Different Technology. ASMScJ 2023; 18: 1-11.
- Hinkle JL, Kerry CH. Textbook of Medical-Surgical Nursing (15th ed.). Philadelphia, USA: Lippincott Williams and Wilkins; 2021.
- Poudyal A, Karki KB, Shrestha N, Aryal KK, Mahato NK, Bista B, Ghimire L, Kc D, Gyanwali P, Jha AK, Garcia-Larsen V, Kuch U, Groneberg DA, Sharma SK, Dhimal M. Prevalence and risk factors associated with chronic kidney disease in Nepal: evidence from a nationally representative population-based cross-sectional study. BMJ Open. 2022 Mar 21;12(3):e057509. doi: 10.1136/bmjopen-2021-057509.
Opintojen ennätyspäivät
Opi tärkeimmät päivämäärät
Opiskelun aloitus (Todellinen)
Ensisijainen valmistuminen (Arvioitu)
Opintojen valmistuminen (Arvioitu)
Opintoihin ilmoittautumispäivät
Ensimmäinen lähetetty
Ensimmäinen toimitettu, joka täytti QC-kriteerit
Ensimmäinen Lähetetty (Todellinen)
Tutkimustietojen päivitykset
Viimeisin päivitys julkaistu (Todellinen)
Viimeisin lähetetty päivitys, joka täytti QC-kriteerit
Viimeksi vahvistettu
Lisää tietoa
Tähän tutkimukseen liittyvät termit
Muita asiaankuuluvia MeSH-ehtoja
Muut tutkimustunnusnumerot
- 038856
Yksittäisten osallistujien tietojen suunnitelma (IPD)
Aiotko jakaa yksittäisten osallistujien tietoja (IPD)?
IPD-suunnitelman kuvaus
Lääke- ja laitetiedot, tutkimusasiakirjat
Tutkii yhdysvaltalaista FDA sääntelemää lääkevalmistetta
Tutkii yhdysvaltalaista FDA sääntelemää laitetuotetta
Nämä tiedot haettiin suoraan verkkosivustolta clinicaltrials.gov ilman muutoksia. Jos sinulla on pyyntöjä muuttaa, poistaa tai päivittää tutkimustietojasi, ota yhteyttä register@clinicaltrials.gov. Heti kun muutos on otettu käyttöön osoitteessa clinicaltrials.gov, se päivitetään automaattisesti myös verkkosivustollemme .